A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia
Clinical trial NCT06589817 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06589817
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2026-06-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.